Results 231 to 240 of about 2,166,017 (392)

High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy

Cell Reports Medicine, 2021
Genghao Chen, Ellen L. Shrock, Mamie Z. Li, J. Spergel, K. Nadeau, J. Pongracic, D. Umetsu, R. Rachid, A. MacGinnitie, W. Phipatanakul, L. Schneider, H. Oettgen, S. Elledge   +12 more
semanticscholar   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Successful Oral Immunotherapy (OIT) Due to Anti-IgE Protection. [PDF]

J Clin Med
Yoosefi Moridani M, Lau S, Beyer K.
europepmc   +1 more source

The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults [PDF]

, 2018
Jarkko Mäntylä, Tuuli Thomander, Auli Hakulinen, Anna Kaarina Kukkonen, Kati Palosuo, Helena Voutilainen, Anna S. Pelkonen, Paula Kauppi   +7 more
openalex   +1 more source

Nanogel‐Mediated Immunotherapy to Tackle Cancer and Inflammatory Diseases

ChemistryEurope, EarlyView.
Nanogels formed through self‐assembly, microemulsion, or precipitation polymerization method enable precise delivery of immunotherapeutic factors and immune cell targeting, thus effectively modulating immune responses. This review highlights recent advances in stimuli‐responsive nanogel design, underlying mechanisms, and their potentials to tackle ...
Ziwen Zhang, Jinxia Wang, Guang‐Zhi Jin, István Bányai, Dzmitry Shcharbin, Ivan Stoikov, Mingwu Shen, Xiangyang Shi   +7 more
wiley   +1 more source

Goldilocks zone: Allergists' perceptions of family anxiety and investment in food allergy oral immunotherapy. [PDF]

Ann Allergy Asthma Immunol
Erol M, Kim EH, Fisher JA.
europepmc   +1 more source

Cow’s milk oral immunotherapy in real life: 8-year long-term follow-up study

, 2018
Inês Mota, Susana Piedade, Angéla Gáspár, Filipe Benito-Garcia, Graça Sampaio, Luís Miguel Borrego, Mário Morais‐Almeida   +6 more
openalex   +2 more sources

Synthetic Cathepsin B Sensitive Adjuvant‐Peptide Conjugates to Target Intracellular Toll‐Like Receptors 7 and 8

ChemistryEurope, EarlyView.
Cathepsin B‐sensitive peptide–adjuvant conjugates are designed, synthesized, and evaluated to deliver an antigenic peptid and an adjuvant targeting Toll‐like receptors 7 and 8 (TLR7/8) to antigen presenting cells. The adjuvant is released by cathepsin B resulting in antigen presentation and TLR mediated T cell activation.
Marjolein M. E. Isendoorn, Giulia Castello, Nico J. Meeuwenoord, Martijn Verdoes, Jeroen D. C. Codée, Ferry Ossendorp, Dmitri V. Filippov   +6 more
wiley   +1 more source

Real-life safety of peanut oral immunotherapy: Results from a French multicenter observational study. [PDF]

J Allergy Clin Immunol Glob
Michaud E, Amat F, Lambert C, Divaret-Chauveau A, Deschildre A, Peanut Oral Immunotherapy Working Party from the French Society of Allergology.   +5 more
europepmc   +1 more source

Efficacy of peanut oral immunotherapy in children : biological markers and predictive factors

, 2018
Lucile Saba
openalex   +1 more source